Trial of One Versus Two Doses of Dexamethasone for Pediatric Asthma Exacerbation

• Status: Completed
• Trial end date: 2017-11-01
• Target enrollment: 0
• Participant gender: All

Summary

Comparing one versus two doses of oral dexamethasone for the treatment of asthma in the pediatric emergency department.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Geoffrey W Jara-Almonte
• Treatments: BB 1101; Dexamethasone; Dexamethasone 21-phosphate; Dexamethasone acetate

Criteria

Inclusion Criteria:

• History of asthma defined as at least two (2) prior episodes of respiratory illness characterized by wheezing treated with inhaled beta agonists

Exclusion Criteria:

• pregnancy

• severe chronic cardiac, respiratory, neurological or neuromuscular disease

• complete resolution of symptoms after one treatment of beta agonists

• severe asthma symptoms as defined by a Pulmonary Index Score of 12 or greater